Monitoring of medical literature and entry of adverse reaction reports into EudraVigilance
The European Medicines Agency (EMA) is responsible for monitoring a number of substances and selected medical literature to identify suspected adverse reactions with medicines authorised in the European Union, and for entering the relevant information into the EudraVigilance database.
Click on this link for more information.
